People

Mark
Sentenac

Atlanta: +1 404 572 3571
msentenac@kslaw.com

Related Capabilities

Mark Sentenac is a Partner in King & Spalding’s Products Liability & Mass Torts group. His practice focuses on defending life sciences, technology, social media, automotive, tobacco, and mining companies in all phases of mass tort, product liability, and cutting-edge “tech tort” litigation across the country. Mark has extensive experience helping companies navigate increasingly risky and complex discovery issues in mass tort litigation. This includes serving as lead discovery counsel to TikTok in the In re Social Media Adolescent Addiction/Personal Injury Litigation, Boehringer Ingelheim in the nationwide Zantac (Ranitidine) Products Liability Litigation, and General Motors in its California breach of warranty docket.

Mark has also been at the forefront of advising companies on the potential product liability risks of implementing AI and routinely engaged by clients and industry groups—including AdvaMed, the world’s largest medical device association—to share his insights. He is a member of the firm’s AI/ML Tactical Operations team and leads the Product Liability & Mass Tort group’s technology and innovation initiatives seeking to achieve better results and drive efficiencies for clients and the firm through implementation of new technologies.

Mark is also widely published on cutting edge litigation issues of significance to the life sciences industry, including Mitigating Risks of Developing Drugs and Devices with AI, Law360 (Jul. 2023)—named by Law360 as a Top Guest Article for 2023—Medical Device Makers Must Review Approach After California Case, Bloomberg Law (Jul. 2024), FDA’s Essure Order Affirms Role of Learned Intermediary, Law360 (Apr 2018), and Will The Learned Intermediary Doctrine Survive A New Paradigm?, Law360 (Jan 2017).

Email Mark

Credentials

J.D., University of San Francisco School of Law, Magna Cum Laude

B.S., University of California-Santa Barbara

California

Georgia

U.S. District Court for the Eastern District of California

U.S. District Court for the Northern District of California

U.S. District Court for the Southern District of California

02.20.2025

Speaking Engagement

Amanda Klingler and Mark Sentenac to Speak at ACI’s 2nd Annual Life Sciences AI Summit

View all events

News

In the News · Source: Law360

December 22, 2023
Mark Sentenac, Micha Gallo and Simran Modi’s article, “Mitigating Risks of Developing Drugs and Devices With AI” is named a Law360 top guest article of 2023

In the News · Source: Pennsylvania Record

March 2, 2023
Mark Sentenac, Ryan Kearney and Susan Clare counsel Allergan and AbbVie in a product liability case before a Pennsylvania federal court

View all

Matters

Member of team serving as national coordinating and trial counsel in nationwide product liability litigation involving a leading pharmaceutical company’s antidepressant medication. Mark’s experience includes trial preparation and briefing dispositive and pre-trial motions.

Acted as national coordinating counsel for a multinational medical device manufacturer in claims related to its orthopedic products, including representing the manufacturer before the U.S. Judicial Panel on Multidistrict Litigation.

Member of team advising multinational pharmaceutical company on recall of popular consumer health product.

Matters

Member of team advising multinational pharmaceutical company on recall of popular consumer health product.

Member of team serving as national trial counsel for medical device manufacturer in multidistrict litigation involving manufacturer’s surgical mesh products. Mark’s experience included preparing manufacturer’s subject matter experts in device design for trial, taking percipient witness depositions throughout the country, briefing dispositive and pre-trial motions, and advising company during investigations by states’ attorneys general.

Member of team representing manufacturer in nationwide litigation involving its complex implantable neurological medical devices. Mark’s experience includes working with company’s subject matter experts on complex scientific fields, briefing complex issues of federal preemption, including successfully defending favorable result before the Fifth Circuit Court of Appeals, and coordinating large-scale electronic discovery.